In response to questions about 2026 guidance, Wallace said category growth appears to have stabilized, but at lower levels than historical assumptions. He cited a range of roughly 1.5% to 2.5% category growth, alongside “significant uncertainty all around the world,” including the risk of higher promotional intensity if demand stays weak.Wallace said Colgate exited the year with organic sales growth in all four categories in the fourth quarter, and showed sequential improvement versus the third quarter in e ...

Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, exceeding the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Group 1: Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange fluctuations [3] Group 2: Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program to enhance growth despite global market uncertainties [2] - Organic sales growth is projected at 1%–2%, which includes a ~70 basis points impact from exiting private-label pet sales [3] Group 3: Analyst Ratings and Price Targets - Following the earnings announcement, various analysts adjusted their price targets for Colgate-Palmolive, with Wells Fargo lowering its target from $80 to $77 and Evercore ISI Group from $100 to $94 [4][6] - JP Morgan and Morgan Stanley both maintained an Overweight rating while lowering their price targets to $87 from $88 and $96 respectively [6] - Citigroup maintained a Buy rating but reduced its price target from $105 to $95 [6]

Core Insights - Colgate-Palmolive Company reported third-quarter adjusted earnings per share of 91 cents, surpassing the analyst consensus estimate of 89 cents, with quarterly sales of $5.131 billion, reflecting a 2% increase in net sales [1][3] Financial Performance - The company’s third-quarter adjusted earnings per share were 91 cents, beating the consensus estimate of 89 cents [1] - Quarterly sales reached $5.131 billion, aligning with market expectations, and net sales increased by 2% [1] - For 2025, Colgate anticipates net sales growth in the low single digits, impacted slightly by foreign exchange [3] Strategic Outlook - Colgate is transitioning to a new 2030 strategy and implementing a Strategic Growth and Productivity Program, aiming to reaccelerate growth amid global market uncertainties [2] - Organic sales growth is projected at 1%–2%, with approximately 70 basis points impact from exiting private-label pet sales [3] Analyst Ratings and Price Targets - Wells Fargo maintained an Underweight rating, lowering the price target from $80 to $77 [6] - Evercore ISI Group maintained an Outperform rating, reducing the price target from $100 to $94 [6] - JP Morgan and Morgan Stanley both maintained Overweight ratings, with price targets adjusted from $88 to $87 and from $96 to $87, respectively [6] - Citigroup maintained a Buy rating, significantly lowering the price target from $105 to $95 [6]

Financial Performance & Guidance - Net sales increased by 20%[18] - Organic sales increased by 04%, led by oral care, including a 08% negative impact from lower private label pet sales[18] - The company returned $21 billion to shareholders year to date[31] - Net sales growth is expected to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange[24] - Organic sales growth is now expected to be 1% to 2%, roughly in line with year-to-date organic sales growth of 12%, including an approximately 70 basis point impact from exit from private label pet sales[25] - The company expects approximately $75 million in tariff costs for 2025[26] Strategic Initiatives - The company announced a new three-year productivity program to drive future top and bottom line growth and support the Company's 2030 strategy[20] - The Strategic Growth and Productivity Program is projected to result in cumulative pre-tax charges totaling between $200 and $300 million over the course of the three-year program[21] - Colgate Bright Smiles, Bright Futures achieved a new milestone - reaching approximately 2 billion children and their families worldwide since 1991[18] Market Share - Global toothpaste market share was up 10 basis points on a volume basis year to date[18] - Global manual toothbrush market share was up 50 basis points on a volume basis year to date[18]